Difference of coagulation features between severe pneumonia induced by SARS-CoV2 and non-SARS-CoV2
Top Cited Papers
- 3 April 2020
- journal article
- research article
- Published by Springer Science and Business Media LLC in Journal of Thrombosis and Thrombolysis
- Vol. 51 (4), 1107-1110
- https://doi.org/10.1007/s11239-020-02105-8
Abstract
Severe coronavirus disease 2019 (COVID-19) is commonly complicated with coagulopathy, the difference of coagulation features between severe pneumonia inducKeywords
Funding Information
- National Mega Project on Major Infectious Disease Prevention of China (2017ZX10103005-007)
This publication has 14 references indexed in Scilit:
- The stimulation of thrombosis by hypoxiaThrombosis Research, 2019
- Acute fibrinolysis shutdown occurs early in septic shock and is associated with increased morbidity and mortality: results of an observational pilot studyAnnals of Intensive Care, 2019
- European guidelines on perioperative venous thromboembolism prophylaxisEuropean Journal of Anaesthesiology, 2018
- More than an anticoagulant: Do heparins have direct anti-inflammatory effects?Thrombosis and Haemostasis, 2017
- New criteria for sepsis-induced coagulopathy (SIC) following the revised sepsis definition: a retrospective analysis of a nationwide surveyBMJ Open, 2017
- Platelet “first responders” in wound response, cancer, and metastasisCancer and Metastasis Reviews, 2017
- Coagulation and sepsisThrombosis Research, 2016
- Low-dose heparin as treatment for early disseminated intravascular coagulation during sepsis: A prospective clinical studyExperimental and Therapeutic Medicine, 2013
- THROMBOMODULIN ALFA IN THE TREATMENT OF INFECTIOUS PATIENTS COMPLICATED BY DISSEMINATED INTRAVASCULAR COAGULATIONShock, 2011
- Pulmonary coagulopathy as a new target in therapeutic studies of acute lung injury or pneumonia—A reviewCritical Care Medicine, 2006